All news (page 54)

1 June 2026

CATL opens world’s largest energy-storage testbed for real-world validation

10-ha, RMB3bn Xiamen facility offers open station-level validation across five labs: 35kV/100MVA grid sim, 1kV–500kV HV tests, 20MW combustion, -50–100°C climate chambers, EMC for 40-ft containers
31 May 2026

Lilly: Retevmo reduces recurrence/death risk by 83% as adjuvant in early‑stage RET‑fusion NSCLC

Phase 3 LIBRETTO-432 randomized 151 early-stage RET‑fusion NSCLC patients; at 24‑month follow‑up EFS rates 92% vs 61% (treatment vs placebo). Safety: elevated ALT/AST manageable with dose changes.
31 May 2026

Johnson & Johnson PROTEUS Phase 3: Perioperative ERLEADA reduces risk of metastasis or death by 20%

Perioperative apalutamide + ADT (6 months pre/post-surgery) raised pCR/MRD to 8.9% vs 1%, delayed need for further therapy >6 vs 3.5 years, met dual primary endpoints; safety profile as expected.
31 May 2026

Johnson & Johnson: RYBREVANT FASPRO shows durable responses in advanced head and neck cancer

Phase 1b/2 OrigAMI-4: subcutaneous amivantamab + hyaluronidase achieved 42% ORR (15% CR) in pretreated recurrent/metastatic HNSCC; median DOR not reached (11.8 mo FU); manageable safety.
29 May 2026

PCC SE confirms Dr. Peter Wenzel as Chairman of the Executive Board until 2031

Supervisory Board decision highlights long-term investor focus and leadership stability amid current market challenges.
29 May 2026

RWE builds 24.7 MWp solar farm for KRONOS TITAN in Nordenham

24.7 MWp PV on 20 ha with >38,300 modules, producing ≈22,000 MWh/year under a long-term PPA to supply a significant share of the site's electricity demand.
29 May 2026

EU advances carbon removals and carbon farming market

CRCF Days launched rollout: certification schemes may seek CRCF recognition; Buyers’ Club to aggregate demand; removals and carbon‑farming methodologies near adoption; financing and de‑risking needed
29 May 2026

Velocys, Tetracore sign MOU to evaluate modular GTL in Nigeria

MOU to assess modular Fischer-Tropsch microFTL for Atakobo GTL in Ogun State - convert ~55 MMSCFD (~5,000 BPD) into diesel, Jet-A1 and naphtha to support domestic fuel supply.
29 May 2026

Johnson & Johnson: RYBREVANT + LAZCLUZE yields 41‑month median OS in first‑line atypical EGFR‑mutant NSCLC

CHRYSALIS-2 Phase1/1b (n=49): first-line atypical EGFR‑mutant NSCLC showed ORR 57%; 3‑yr OS 55%, 4‑yr OS 46%; 41% remained on treatment ≥2 years; safety consistent with prior reports.
29 May 2026

Petrobras to invest over R$70 billion in Sergipe

R$70B in Sergipe funds SEAP deep-water (P-81/P-87 FPSOs: 240k bpd, gas processing), 32 wells, 134 km pipeline; R$12.5B decommission 26 shallow platforms; fertilizer restarted (1.8k t/d)
29 May 2026

Rompetrol Rafinare Q1 2026: Turnover up 8%, net profit achieved

Q1: EBITDA $27.5M; March shutdown (700+ tasks) completed; Petromidia processed ~1.2Mt, white product yield 83.76%; domestic fuel share 66%; state contribution $577M
29 May 2026

Chevron names Scott A. Keller general counsel

Scott A. Keller joins July 1 as general counsel, reports to R. Hewitt Pate, will succeed him as chief legal officer Jan 1, 2027. Keller is a leading appellate lawyer and former Texas Solicitor General.
29 May 2026

Johnson & Johnson: TECVAYLI improves PFS and OS in second-line multiple myeloma

Phase 3 MajesTEC‑9: teclistamab cut progression/death risk 71% (HR 0.29) and death 40% (HR 0.60) vs PVd/Kd in early RRMM; higher ≥CR (65.9% vs 16.8%); infections and CRS increased
29 May 2026

Futerro CEO Van Gansberghe Reappointed to European Bioplastics Board, Named Co-Chair

Will push for EU policies supporting bio-based, biodegradable and compostable plastics—replace fossil carbon where valuable, enable circularity and strengthen resilient industrial value chains.
29 May 2026

EU Innovation Fund Net‑Zero Call: 358 applications, €17.5bn requested (6× budget)

Applicants across 27 countries submitted large/medium/small projects, pilots and cleantech manufacturing for energy‑intensive, carbon management, renewables and storage; results Oct 2026
29 May 2026

Merck: FDA Grants Breakthrough Designation to Calderasib (MK‑1084) for First‑Line KRAS G12C‑Mutant Metastatic NSCLC

Supports calderasib plus pembrolizumab in PD‑L1 ≥1% newly diagnosed metastatic KRAS G12C NSCLC; positive Phase 1 KANDLELIT‑001 data; multiple Phase 3 trials planned; developed with Taiho/Astex
29 May 2026

IFF to sell Food Ingredients business to CVC

Food Ingredients business sold for ~$4.3B (≈10x EBITDA); seller retains ~10% stake; net proceeds ~$3.8B for debt reduction, buybacks and reinvestment; close by end Q2 2027.
29 May 2026

Uniper appoints Tina Hinz General Counsel & Chief Compliance Officer

Tina Hinz becomes General Counsel & CCO on June 1, 2026. Ex-Linklaters, at the firm since 2016; led financings, trading compliance, crisis stabilisation and EU compliance rollout.
29 May 2026

AGC verifies AFLAS FFKM fluorine as 100% recycled under UL 2809

Mass-balance allocation applied to AFLAS FFKM; product offers strong chemical/heat/plasma resistance for semiconductor seals. Part of effort to recycle plant fluorine waste and advance circularity.
29 May 2026

KazMunayGaz 2025 Sustainability Report

2025 report (GRI 2021) discloses 2023-2025 economic, environmental and social KPIs; includes SASB, IFRS S2 climate reporting with scenario analysis, GHG targets and independent verification
29 May 2026

Eni and Seri Industrial to develop LFP stationary battery supply chain

Agreement to build integrated LFP battery platform: cell/module plants, BESS assembly, recycling and cathode production. 2nd gigafactory >8 GWh by 2029; BESS line ready H1 2027. 30% stake for €55m.
29 May 2026

Arkema names Laurent Tellier COO

From July 1, 2026 the new COO replaces Marc Schuller (advisor until Sept 30). He'll head Adhesives, Advanced Materials, Coatings and Primary Materials; HPP and Fluorogases until a successor joins.
28 May 2026

SLB Capturi demonstrates carbon capture at NG Nordics Nyborg hazardous‑waste plant

Post‑combustion capture piloted at a high‑temperature hazardous‑waste incinerator in Denmark; first global demo, showing robust energy, capture rate and emissions performance.
28 May 2026

Metsä Group opens modernised Mariestad tissue mill

€370m rebuild doubles capacity to ~145,000 t/yr; new production line and three converting lines; improved energy efficiency, lower water use and emissions.
28 May 2026

National Power Supply (Double A Group) orders ANDRITZ recovery boiler and evaporation plant

New bioenergy unit will process black liquor to generate steam and green electricity, recover chemicals for reuse; start-up set for Q2 2028; order in high double-digit million euros.
28 May 2026

Johnson & Johnson: FDA approves TREMFYA label update for PsA joint‑damage inhibition

APEX Phase‑3b: in biologic‑naïve PsA patients, 24‑week results met ACR20 and significantly inhibited structural joint damage vs placebo; placebo switchers had 57% less radiographic progression to Week 48; safety unchanged.
28 May 2026

SkyNRG and KLM start construction of Netherlands' first dedicated SAF plant

Construction begins on DSL-01. First commercial-scale SAF plant to secure non‑recourse financing; aims for ~100,000 t/yr by 2028 via HEFA from low‑quality feedstocks, >100 jobs and €16M JTF support.
28 May 2026

Aptar Pharma files patents and reports preclinical proof‑of‑concept for intranasal and pulmonary GLP‑1 delivery

Published three international patent applications for nasal/pulmonary GLP‑1 formulations (spray‑dried/powder). Preclinical semaglutide PK shows up to 10× Cmax vs oral; ongoing biologics delivery work.
28 May 2026

Uniper appoints Christian Ohlms Chief Commercial Officer

Christian Ohlms named Chief Commercial Officer effective Oct 1, overseeing trading/sales in power, gas, LNG and low‑carbon commodities and leading commodity trading realignment. Former SEFE MD.
28 May 2026

GSK’s bepirovirsen: 19% functional cure in Phase III chronic hepatitis B trials

Pooled Phase III trials: 26% functional cure in patients with ≤1000 IU/mL HBsAg; 49% reached qHBsAg ≤100 IU/mL at 1 year; acceptable safety; regulatory reviews and anticipated Q3 2026 decisions.

← Previous Next →